drugset / Trial / NCT02625870

Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides

NCT02625870 ↗

Phase 3 Unknown 240 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The trial was a double-blind, randomized, parallel-group study comparing Omega-3-Acid Ethyl Esters 90 Soft Capsules and placebo. The primary objective of the present study was to evaluate the efficacy and safety of Omega-3-Acid Ethyl Esters 90 Soft Capsules in subjects with severe hypertriglyceridemia (TGs ≥500 mg/dL but \<2000 mg/dL).

Timeline

Start
2015-12
Primary completion
2016-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3-Acid Ethyl Esters 90 Soft Capsules Unknown 4 g Oral

Indications